--- title: "Home" canonical: "https://www.pharmalegacy.com/" lastmod: "2026-07-02T14:09:29+00:00" generator: "llm-mirrors/1.0.19" --- Catawba Research Announces Strategic Partnership With PharmaLegacy Laboratories The partnership allows our organizations to provide end-to-end drug development solutions for pharmaceutical clients. Read the Press Release PharmaLegacy acquires BioLegacy Research PharmaLegacy acquires preclinical CRO BioLegacy Research, strengthening its preclinical services and expanding laboratory operations into North America Expect More From Your Preclinical CRO No animal study can predict with certainty how a therapy will perform in humans, but with over 1,500 validated in vivo efficacy models, we ensure they come as close as possible. Our Services Over 100 Different Indications PharmaLegacy conducts studies across a wide breadth of therapeutic areas. View All Indications Being Correct Is Everything Critical pipeline decisions need to be based on correct information. For you, your company, and your patients. Our Ethos Set Your Expectations High Contact PharmaLegacy and let’s discuss how we can exceed them. Start your study NOW Why wait months to start your study? Most of our models are available immediately. Contact us and you could be collecting data in under two weeks! Get Started Expect More From Your Preclinical CRO No animal study can predict with certainty how a therapy will perform in human subjects, yet that is what you need them to do. You need to get as much information from them as possible. Due to study design, the models and technologies available, or lack of proper expertise, most preclinical, in-vivo pharmacological studies are not providing as much information as they could be. These missing insights can derail a pipeline. Missed opportunities are not what you expect from your preclinical CRO. You expect more. Now you can do so confidently. You can expect more from PharmaLegacy because PharmaLegacy has more: more models, more experience, and more focus. We have over 1,500 validated translational animal models, including non-human primate models and many humanized rodent models, spanning over 100 different indications in the fields of cancer, auto-immunity, inflammation and bone. Our staff has an average of 15 – 20 years of pharmacology experience, and most of them have been with PharmaLegacy for more than 5 years. When you search for a preclinical CRO, set your expectations high. Contact PharmaLegacy and let’s discuss how we can exceed them. Oncology / Immuno-Oncology Inflammation, Immunity & Autoimmunity Metabolic Disease Models Hepatic & Renal Disease Models Cardiovascular Disease Models Respiratory Disease Models Musculoskeletal Models Ocular Disease Models Otology / Auditory Models Pain & Analgesia Models Neuroscience Models Infectious Diseases the tools to excel, and the people to execute. To ensure you get the answers you need, you can’t have any weak links in your studies. PharmaLegacy’s experienced scientific staff continuously develop and validate new models to ensure that your critical pipeline decisions are made based on accurate and dependable information. Pharmacokinetics and Pharmacodynamics (PK/PD) Non-Human Primate Studies Histopathology Biomarker Discovery & Detection Medical Device Testing DMPK In Vitro Efficacy and Safety Testing 1,500+ Animal Models Available Immediately 100+ Indications 30,000+ Animal Capacity 380,000 Square Feet of Facility Space INDs supported Pharmaceutical companies trust PharmaLegacy There’s a lot on the line. Let PharmaLegacy get the correct answers. +86-21-6176-5100*8051 +1-617-803-9415 info@pharmalegacy.com “The study they delivered on a very reasonable budget was top notch […] The model was executed flawlessly.” See why a top-20 pharmaceutical company trusts PharmaLegacy for their preclinical immuno-oncology trials. download the case study ✕ Download the Case Study